Respiratory Syncytial Virus (RSV)
- The US Food and Drug Administration (FDA) granted approval for the first vaccine designed to safeguard newborns from Respiratory Syncytial Virus (RSV).
- Respiratory Syncytial Virus (RSV) primarily affects the lungs and respiratory tract, posing a significant risk to children and the elderly.
- Pfizer's newly approved vaccine is intended to safeguard newborns by administering it to mothers during the latter stages of pregnancy.
- This approach ensures protection for infants during their critical first six months of ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
News Snippets
- 1 India-Bhutan Hold Talks on Boundary and Cooperation
- 2 New Species of Congrid Eel Discovered
- 3 Delhi Becomes the 28th Legislature to Join NeVA
- 4 U.S. Withdraws from U.N. Climate Damage Fund Board
- 5 India and Vietnam Hold Fourth Policy Planning Dialogue
- 6 US Targets India’s High Tariffs
- 7 India and Armenia Sign MoU on Medical Product Regulation
- 8 Poland & Baltic States to Withdraw from Ottawa Convention
- 9 India and Mongolia Strengthen Strategic Partnership
- 10 New Freshwater Algae Species Discovered in Western Ghats
